SGI

SEC Filing Summary: Tempur-Pedic International Inc. (10-Q)

Business Context and Reporting Period

This Quarterly Report on Form 10-Q covers the period ended March 31, 2006. Tempur-Pedic International Inc. is a global manufacturer and marketer of premium viscoelastic mattresses and pillows, operating primarily through two segments: Domestic (U.S.) and International (Denmark-based manufacturing serving global markets). The company sells products in over 70 countries through retail, direct, healthcare, and third-party distribution channels.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 3% year-over-year, driven by an 8% increase in Retail channel sales. However, Direct and Healthcare channels declined by 23% and 13%, respectively.
• Margin Compression: Gross profit decreased 3% despite revenue growth. Gross margin declined from 51.4% to 48.7% due to a shift in product mix toward lower-margin mattresses, increased raw material costs (chemicals and fuel), and the impact of a stronger U.S. dollar (negative $7.0 million impact).
• Share Repurchases: The company repurchased 8.0 million shares for $98.2 million in Q1 2006, significantly reducing the share count and boosting EPS despite flat net income.
• Debt Levels: Total debt increased to $398.2 million from $344.5 million. This increase was primarily due to borrowing $79.0 million on the domestic revolving credit facility to fund share repurchases, partially offset by a $27.6 million principal reduction on the Foreign Term Loan.
• Working Capital: Working capital decreased 18% to $88.4 million, driven by lower inventory levels and higher accounts payable and accrued expenses.

Guidance, Outlook, and Risks

• Capital Expenditures: The company expects capital expenditures of approximately $25.7 million for the remainder of 2006, largely for the completion of a new manufacturing facility in New Mexico (total project cost estimated at $90–$95 million).
• Cost Pressures: Management anticipates continued downward pressure on gross margins due to raw material cost increases and the strategic shift toward the Retail channel, which operates at wholesale prices.
• Legal Proceedings: The company is defending against a consolidated securities class action lawsuit alleging false disclosures regarding competition and financial performance between April and September 2005. Additionally, derivative complaints have been filed against officers and directors regarding alleged insider trading. Management believes these claims lack merit but notes the uncertainty of litigation outcomes.
• Market Risks: Significant exposure to foreign exchange fluctuations (approx. 34% of sales in foreign currency) and interest rate risk on variable-rate debt ($299.3 million outstanding). A 100 basis point increase in interest rates would reduce pre-tax income by approximately $3.0 million annually.

Investor Verification Checklist

• Margin Sustainability: Verify if the company can offset rising raw material costs and the lower-margin retail mix with pricing power or efficiency gains.
• Share Repurchase Impact: Assess the long-term capital allocation strategy given the heavy reliance on debt to fund the $180 million share repurchase program.
• Legal Exposure: Monitor the status of the securities class action and derivative lawsuits for potential financial impact or management distraction.
• New Facility Progress: Track the completion timeline and cost overruns for the New Mexico manufacturing facility, which is critical for future capacity.
• Channel Mix: Evaluate the sustainability of the decline in Direct and Healthcare channels as the company pivots toward Retail distribution.